About Index Trending news
Analyze
Pricing
Prosensa

Prosensa

Work at Prosensa? Add yourself to this profile

Prosensa

We aim to develop innovative, RNA-modulating therapeutics to address unmet medical needs for patients with rare genetic diseases
Edit Profile
More info

Elsewhere

Also headquartered in Leiden

TransIP TransIP VarmX VarmX Landscape Landscape Pluriomics Pluriomics Toxys Toxys Prosensa investors Prosensa investors eKids eKids UrbanPopUpAmsterdam UrbanPopUpAmsterdam Infradata Infradata Interpulse Interpulse

Companies in the same industry

Adnexus Adnexus Fulgent Diagnostics Fulgent Diagnostics eXIthera Pharmaceuticals eXIthera Pharmaceuticals Theranica Theranica GigaGen GigaGen Codiak Biosciences Codiak Biosciences Arsia Therapeutics Arsia Therapeutics Bioverativ Bioverativ Morphogen-IX Morphogen-IX Comfort Line Comfort Line

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
Acquired by
24 Nov 2014
BioMarin Pharmaceutical
$840,000,000
Latest funding Show all
Grant
$200,000
Venture capital
$29,766,600
Locations
HQ
Leiden, The Netherlands
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Prosensa makes some noise.